460 related articles for article (PubMed ID: 11526489)
21. Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance.
Friedrich K; Wieder T; Von Haefen C; Radetzki S; Jänicke R; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2001 May; 20(22):2749-60. PubMed ID: 11420687
[TBL] [Abstract][Full Text] [Related]
22. Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis.
Chen JS; Konopleva M; Andreeff M; Multani AS; Pathak S; Mehta K
J Cell Physiol; 2004 Aug; 200(2):223-34. PubMed ID: 15174092
[TBL] [Abstract][Full Text] [Related]
23. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation.
Chen T; Wong YS
Int J Biochem Cell Biol; 2009 Mar; 41(3):666-76. PubMed ID: 18718551
[TBL] [Abstract][Full Text] [Related]
24. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of acetaminophen-induced apoptosis in cultured cells: roles of caspase-3, DNA fragmentation factor, and the Ca2+ and Mg2+ endonuclease DNAS1L3.
Boulares AH; Ren T
Basic Clin Pharmacol Toxicol; 2004 Jan; 94(1):19-29. PubMed ID: 14725611
[TBL] [Abstract][Full Text] [Related]
26. Retinoid-related molecules require caspase 9 for the effective release of Smac and the rapid induction of apoptosis.
Lopez-Hernandez FJ; Ortiz MA; Bayon Y; Piedrafita FJ
Cell Death Differ; 2004 Feb; 11(2):154-64. PubMed ID: 14576769
[TBL] [Abstract][Full Text] [Related]
27. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells.
Blanc C; Deveraux QL; Krajewski S; Jänicke RU; Porter AG; Reed JC; Jaggi R; Marti A
Cancer Res; 2000 Aug; 60(16):4386-90. PubMed ID: 10969782
[TBL] [Abstract][Full Text] [Related]
28. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop.
von Haefen C; Wieder T; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2003 Apr; 22(15):2236-47. PubMed ID: 12700660
[TBL] [Abstract][Full Text] [Related]
29. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.
Milner AE; Palmer DH; Hodgkin EA; Eliopoulos AG; Knox PG; Poole CJ; Kerr DJ; Young LS
Cell Death Differ; 2002 Mar; 9(3):287-300. PubMed ID: 11859411
[TBL] [Abstract][Full Text] [Related]
30. Phytosphingosine induces apoptotic cell death via caspase 8 activation and Bax translocation in human cancer cells.
Park MT; Kang JA; Choi JA; Kang CM; Kim TH; Bae S; Kang S; Kim S; Choi WI; Cho CK; Chung HY; Lee YS; Lee SJ
Clin Cancer Res; 2003 Feb; 9(2):878-85. PubMed ID: 12576463
[TBL] [Abstract][Full Text] [Related]
31. The p53 stabilizing compound CP-31398 induces apoptosis by activating the intrinsic Bax/mitochondrial/caspase-9 pathway.
Luu Y; Bush J; Cheung KJ; Li G
Exp Cell Res; 2002 Jun; 276(2):214-22. PubMed ID: 12027451
[TBL] [Abstract][Full Text] [Related]
32. Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells.
Hopkins-Donaldson S; Yan P; Bourloud KB; Muhlethaler A; Bodmer JL; Gross N
Oncogene; 2002 Sep; 21(39):6132-7. PubMed ID: 12203125
[TBL] [Abstract][Full Text] [Related]
33. Caspase-3 activation during apoptosis caused by glutathione-doxorubicin conjugate.
Asakura T; Sawai T; Hashidume Y; Ohkawa Y; Yokoyama S; Ohkawa K
Br J Cancer; 1999 May; 80(5-6):711-5. PubMed ID: 10360648
[TBL] [Abstract][Full Text] [Related]
34. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation.
Stepczynska A; Lauber K; Engels IH; Janssen O; Kabelitz D; Wesselborg S; Schulze-Osthoff K
Oncogene; 2001 Mar; 20(10):1193-202. PubMed ID: 11313863
[TBL] [Abstract][Full Text] [Related]
35. Antimycin A-induced killing of HL-60 cells: apoptosis initiated from within mitochondria does not necessarily proceed via caspase 9.
King MA
Cytometry A; 2005 Feb; 63(2):69-76. PubMed ID: 15655802
[TBL] [Abstract][Full Text] [Related]
36. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY
Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001
[TBL] [Abstract][Full Text] [Related]
37. Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Rabi T; Wang L; Banerjee S
Breast Cancer Res Treat; 2007 Jan; 101(1):27-36. PubMed ID: 17028990
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB.
Schmelz K; Wieder T; Tamm I; Müller A; Essmann F; Geilen CC; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2004 Sep; 23(40):6743-59. PubMed ID: 15273737
[TBL] [Abstract][Full Text] [Related]
39. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor.
Katoh O; Takahashi T; Oguri T; Kuramoto K; Mihara K; Kobayashi M; Hirata S; Watanabe H
Cancer Res; 1998 Dec; 58(23):5565-9. PubMed ID: 9850095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
